Carl T Montague

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi The perils of portliness: causes and consequences of visceral adiposity
    C T Montague
    Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, UK
    Diabetes 49:883-8. 2000
  2. ncbi Adipose depot-specific effects of PPAR gamma agonists: a consequence of differential expression of PPAR gamma in adipose tissue depots?
    Carl T Montague
    AstraZeneca Pharmaceuticals, Macclesfield, UK
    Diabetes Obes Metab 4:356-61. 2002

Collaborators

Detail Information

Publications2

  1. ncbi The perils of portliness: causes and consequences of visceral adiposity
    C T Montague
    Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, UK
    Diabetes 49:883-8. 2000
    ..Here we attempt to summarize the growing body of data relevant to these key areas and, in particular, to illustrate how recent advances in adipocyte biology are providing the basis for new pathophysiological insights...
  2. ncbi Adipose depot-specific effects of PPAR gamma agonists: a consequence of differential expression of PPAR gamma in adipose tissue depots?
    Carl T Montague
    AstraZeneca Pharmaceuticals, Macclesfield, UK
    Diabetes Obes Metab 4:356-61. 2002